SCHEMBL5373331

SCHEMBL5373331

O=C(CCC1CCCNC1)Nc1ccc2c(c1)C(=Cc1ccc[nH]1)C(=O)N2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLK2 Q86UE8 6/20 0.67
▸ HDAC3 O15379 4/20 0.65
▸ HDAC1 Q13547 4/20 0.65
▸ HDAC2 Q92769 4/20 0.65
▸ PDGFRB P09619 4/20 0.65
▸ HDAC6 Q9UBN7 3/20 0.65
▸ KDR P35968 3/20 0.65
▸ FLT1 P17948 2/20 0.65
▸ HDAC4 P56524 2/20 0.65
▸ HDAC7 Q8WUI4 2/20 0.65
▸ HDAC10 Q969S8 2/20 0.65
▸ HDAC11 Q96DB2 2/20 0.65
▸ HDAC8 Q9BY41 2/20 0.65
▸ HDAC9 Q9UKV0 2/20 0.65
▸ HDAC5 Q9UQL6 2/20 0.65
▸ PDGFRA P16234 2/20 0.64
▸ PDPK1 O15530 3/20 0.59
▸ AKT2 P31751 1/20 0.59
▸ PDK1 Q15118 1/20 0.59
▸ JAK3 P52333 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8429175 0.83 PAK1 (0.68) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL8429168 0.83 PAK1 (0.68) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL5369667 0.82 HDAC3 (0.65) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL5357950 0.82 PAK1 (0.46) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL5362266 0.81 HDAC3 (0.46) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL22682 0.79 PDGFRB (0.85) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL22683 0.79 PDGFRB (0.85) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL21115 0.79 HDAC3 (1.00) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL21116 0.79 HDAC3 (1.00) TLK2HDAC3HDAC1HDAC2PDGFRB
SCHEMBL12473992 0.78 PDGFRB (0.85) TLK2HDAC3HDAC1HDAC2PDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 — — US disclosed
EP-1247803-A2 Indolinone compounds suitable for modulation of protein kinases Sugen, Inc. (US) 2002-10-09 — — EP disclosed
EP-0929520-A1 INDOLINONE COMBINATORIAL LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASE Sugen, Inc. (US) 1999-07-21 — — EP disclosed
WO-1998007695-A1 INDOLINONE COMBINATORIAL LIBRARIES AND RELATED PRODUCTS AND METHODS FOR THE TREATMENT OF DISEASE SUGEN, INC. (US) 1998-02-26 — — WO disclosed
Send feedback